Pulmonary arterial hypertension, Who group 1 (see Pulmonary hypertension#Causes), in humans in commonly treated with specific pulmonary artery vasodilators that increase survival such as the prostacyclin I2 (PGI2) mimetics including Treprostinil, epoprostanol, Iloprost, and beraprost.
Pulmonary arterial hypertension in humans is commonly treated with targeted medications that increase survival. These treatments include specific pulmonary artery relaxants such as the prostacyclin I2 (PGI2) analogs Treprostinil, epoprostanol, Iloprost, and beraprost.